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ABSTRACT 
Infection with Hepatitis C Virus (HCV) is a public health problem. Worldwide, there are about 170 million people infected with 
HCV. HCV is transmitted through sex and use of contaminated sharp objects during tattooing or intravenous drug abuse. These 
routes make youth to be more vulnerable. Transfusion and mother to child transmissions are also documented modes.  This 
study was carried out to determine sero-prevalence of hepatitis C virus infection among in school youth at Achievers University, 
Owo in southwest Nigeria. Samples of blood were collected from 70 undergraduate students and sera harvested were tested for 
the presence of antibodies against hepatitis C virus by Enzyme Immunoassay Technique. Most participants fall within age 
range 21-25 (91.4%). The study showed that none of the subjects was positive for anti- HCV antibodies. Education and 
awareness level might have impacted positively on this outcome. Thus routine screening for HCV and sustained awareness 
creation activities to eradicate HCV and its attendant consequences from our society is of paramount importance.  
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ABSTRAIT                                                                                                                                                                                                                
L'infection par le virus de l'hépatite C (VHC) est un problème de santé publique. À l'échelle mondiale, environ 170 millions de 
personnes sont infectées par le VHC. Le VHC se transmet par le sexe et l'utilisation d'objets tranchants contaminés au cours du 
tatouage ou de l'abus de drogues par voie intraveineuse. Ces itinéraires rendent les jeunes plus vulnérables. La transfusion et 
les transmissions mère-enfant sont également des modes documentés. Cette étude visait à déterminer la prévalence de la 
séropositivité au virus de l'hépatite C chez les jeunes scolarisés de l'Université Achievers, à Owo, dans le sud-ouest du Nigéria. 
Des échantillons de sang ont été prélevés chez 70 étudiants de premier cycle et les sérums prélevés ont été testés pour détecter la 
présence d'anticorps contre le virus de l'hépatite C par la technique d'immunoanalyse enzymatique. La plupart des participants 
sont âgés de 21 à 25 ans (91,4%). L'étude a montré qu'aucun des sujets n'était positif pour les anticorps anti-VHC. Le niveau 
d'éducation et de sensibilisation pourrait avoir eu un impact positif sur ce résultat. Le dépistage systématique du VHC et des 
activités de sensibilisation soutenue visant à éradiquer le VHC et les conséquences qui en découlent pour notre société sont de 
la plus haute importance.                                                                                                                                                                                                                            
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Viral hepatitis is a life threatening liver disease, 
caused majorly by hepatitis B and C viruses, and is a 
major public health problem; particularly in 
developing countries (1,2). Hepatitis C is an infectious 
disease affecting primarily the liver, caused by the 
hepatitis C virus (HCV). HCV is a single-stranded 
RNA virus of the flavivirus family, about 9.5 kb in 
length. HCV has a long lag time between onset of 
infection and clinical manifestation of liver disease 
which may be up to 20 years (3). 
HCV has become a significant causative factor in the 
aetiology of chronic liver disease worldwide (4). 
Individuals with chronic infection of HCV have a 
high risk of liver cirrhosis and hepatocellular 
carcinoma. Serological markers for HCV are screened 
in blood banks and antenatal clinics routinely. The 
evaluation of the data of the prevalence of the HCV 
antibodies among patients gives an idea for the 
epidemiology of these infections in the community 
(5). The prevalence of HCV in a population can be 
predicated on risk factors associated with the 
transmission of infection such as blood transfusion, 
intravenous drug abuse, unsafe injections, sexual 
activity, shared needle, other body fluids such as 
semen, virginal secretions and breast milk, from 
mother to child, needle stick injury, ear piercing, 
tattooing and scarifications, exposure to barbers 
razors, surgical procedures and vertical transmission. 
(6,7,8,9,10). Viral hepatitis during pregnancy is 
associated with high risk of maternal complication the 
virus can be transmitted through infected blood, 
mother to child in perinatal period. Perinatal 
transmission is the most common mode of HCV 
transmission worldwide (11). Viral infection is public 
health problem and is highly endemic in the sub- 
Saharan Africa (12, 13). Prevalence rates of anti-HCV 
antibodies have been determined for various nations 
of the world. Nigeria as one of the countries highly 
endemic for viral hepatitis was reported to have a 
prevalence rate of 3.6% through 12.3% (14, 24). 
Though HCV infections are known to occur in the 
general population, the mode of transmission makes 
youth rather more vulnerable.  
The infection is often asymptomatic, but chronic 
infection can lead to scarring of the liver and 
ultimately to cirrhosis, which is generally apparent 
after many years. In some cases, those with cirrhosis 
will go on to develop liver failure, liver cancer, or life-
threatening esophageal and gastric problems (25).  
The aim of this work is to determine the sero-
prevalence of hepatitis C viral infection among in 
school youths at Achievers University in Owo with a 
view to examine the effect of education on 
transmission of HCV. 
 
MATERIALS AND METHODS 
Study setting: This study was carried out at Achievers 
University, Idashen, Owo in southwestern Nigeria.  
The University is a private sector initiative established 
in 2007 and it houses students from all major tribes in 
Nigeria running undergraduate programs in various 
departments of the 2 faculties. Owo is situated 
halfway between the Nigerian towns of Ife and Benin. 
The primary occupation of Owo people is farming 
and trading. They are producers of cocoa, cotton and 
timber. 
Study subjects: A total of 70 apparently healthy 
students of the university who consented to 
participate in the study were recruited. All the 
participants were offered pre-test and post-test 
counseling.  
Procedure: Five milliliters (5ml) of venous blood were 
collected from each subject by venepuncture into 
vacuum plain tube. The specimens were centrifuged 
at 1200 revolution per minute (rpm) for 5 minutes to 
harvest serum into a microtube for the anti-HCV 
(IgG) testing with third generation Enzyme Immuno-
Assay (EIA) method. Donor’s serum was added to the 
microwell together with a second antibody 
conjugated with the enzyme horseradish peroxidase 
(the HRP-Conjugate) and directed against a different 
epitopes of HCV. During incubation, the specific 
immunocomplex formed in case of presence of anti-
HCV in the sample, was captured on the solid phase 
which generates an optical signal that is proportional 
to the amount of anti-HCV antibodies present in the 
sample. The commercially prepared positive and 
negative controls were treated alongside the 
specimens. A cut-off value was determined and 
results were interpreted as positive and negative 
according to manufacturer’s instructions. 
Statistical analysis: The data generated were coded, 
entered, validated and analyzed using Statistical 
Package for Social Science (SPSS) version 20.0. The 
seroprevalence of HCV were expressed for the entire 
study group and documentation of partipants’ age, 
gender, knowledge and attitude was done.  
RESULTS 
A total of 70 healthy Achievers students within the 
age range of 15-30, were tested for HCV. The 
distribution of HCV in relation to age and gender was 
determined. Majority of the respondents were in the 
age range of 21-25years. Out of 70 respondents, thirty 
nine were males (56%) and twenty one were females 
(44%). The sero-prevalence of HCV obtained from this 






TABLE 1: AGE DISTRIBUTION AND 
































TABLE 4.3: RESPONDENT’S AWARENESS ON THE 
ROUTE OF TRANSMISSION OF HEPATITIS C 





















Seventy healthy students were examined for presence 
of marker of HCV infections. The age range of 
subjects was 15-30 years. There was no sero-positivity 
to this viral infection among the subjects studied. No 
prevalence of HCV infection in this community was 
found and this is in contrast to reports from some 
countries in Western Pacific (3.9%), South East Asia 
(2.15%), America (1.17%), Europe (1.03%) and Eastern 
Mediterranean (26)  (4.6%). It is still at variance with 
reports from some researchers about the entire Africa 
(5.3%) (26) and Egypt (20.0%)  (15). In Enugu where 
14.9% was reported (16); the 5.2% and 11.09% 
reported in Jos and Kaduna respectively (15)  were all 
higher than what was reported in this study. The 
sero-prevalence of anti-HCV antibodies reported in 
this study differs from previous studies including the 
13.3% reported for Anti-HCV in Keffi; Nigeria (17). 
The 9.2% found by Ogunro et al. 2007 (27) in Osun 
State; the 8.4% anti-HCV antibody seroprevalence 
rate reported in Lagos (28); the 3.0% found by Ezeani 
(29) in Southeastern, Nigeria; the 2.4% HCV infection 
rate found by Olokoba et al (21); the 1.1% reported by 
Buseri et al (22) for HCV in Osogbo; Nigeria are all 
alarming. However, our report is exactly the same 
with 0.0% HCV seroprevalence previously reported 
by Elfaki (30) in Sudan, another African country. The 
zero level prevalence reported in this study and that 
of Sudan may be due to high level of awareness and 
adherence to safety practices among the participants 
in the studies. No doubt, students of the Achievers 
University, Owo have enough information on 
transmission of HCV and their attitudes generally 
about transfusion transmissible infections reflect their 
level of awareness. 
 
CONCLUSION                                                                                                      
In conclusion, the results of this study have 
highlighted that HCV infection is not common in 
Owo. However, a prospective cohort study is 
suggested for newly admitted students till their year 
of graduation for HCV seroprevalence in order to 
affirm our observation. 
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